OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

J. R. Currier^*, M. De Souza, S. Ratto-Kim, R. Paris, V. Nguay, J. Cox, P. Earl, B. Moss, S. Sriplienchan, P. Thongcharoen, J. Kim, M. Robb, N. Michael, M. Marovich

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate